Policy

Policy articles provide in-depth analysis of social and public policy, examining their wide-ranging impacts on economics, social life, public health, individual liberty, evidence-based decision-making, and institutional accountability.

We cover critical areas such as healthcare and vaccination policies, pandemic responses and WHO, economic subsidies, national security strategies, withdrawals from international bodies, and pathways to reform that restore freedom, truth, and human dignity over centralized control.

All articles from Brownstone Institute are translated into multiple languages to support global access, foster international dialogue on governance and reform, and empower readers worldwide to challenge flawed interventions.

FDA Leadership’s “Blind Spots” Leads to a Surge in Medical Device and Drug Recalls

FDA Leadership’s “Blind Spots” Lead to a Surge in Medical Device and Drug Recalls

SHARE | PRINT | EMAIL

The FDA possesses the legal authority, institutional framework, and technical expertise necessary to solve this problem. What is missing is leadership’s willingness to demand the standards that once defined American drug regulation and legacy records of a low number of recalls.

FDA Leadership’s “Blind Spots” Lead to a Surge in Medical Device and Drug Recalls Continue Reading

Should an Industry-Friendly Rider in the Farm Bill Override Over 1,000 State Laws?

Should an Industry-Friendly Rider in the Farm Bill Override Over 1,000 State Laws?

SHARE | PRINT | EMAIL

If Congress adopts sweeping federal preemption in this area, it will not merely reshape meat markets; it will establish a precedent that states may no longer meaningfully govern the terms under which food is produced and sold within their own borders.

Should an Industry-Friendly Rider in the Farm Bill Override Over 1,000 State Laws? Continue Reading

Join 30,000+ Independent Readers: Get the FREE Brownstone Journal Newsletter